Contattaci contattaci
Home / Investors / Biofarma Group appoints Gianfranco Nazzi as new CEO
March 1st, 2023

Biofarma Group appoints Gianfranco Nazzi as new CEO

Biofarma Group, the European leader in the development and production for third parties of food supplements, medical devices, and cosmetics, with a particular focus on the probiotics segment – controlled by Ardian and the Scarpa family – announces the appointment of Gianfranco Nazzi as its new Chief Executive Officer.

Born in Udine, Gianfranco Nazzi has over 20 years of international experience in several leading multinational companies in the pharmaceutical sector, where he held several managerial positions of great responsibility. Prior to joining Biofarma, Mr. Nazzi served as CEO of Almirall, a leading international pharma company focused on dermatology. Before that, he covered roles of increasing responsibility at Teva, in which he served as Executive Vice President of the International Markets Region and as a member of the Executive Committee. Previously, he also held a series of senior managerial positions in other large multinational pharmaceutical companies such as AstraZeneca, GSK, and Eli Lilly, in various geographical areas including Italy, the United Kingdom, Serbia, and the United States.

In his new role, Gianfranco Nazzi, thanks to his extensive managerial experience and deep expertise in commercial, R&D, and manufacturing, will lead the Group with the aim to continue its organic and inorganic growth path, focusing on internationalization and on the development of new products and innovative technologies for its clients.

“It is a great honor to lead a firm like Biofarma, which is evolving and growing day after day. This is an extremely stimulating challenge for me, that I accept with great determination and passion” – said Gianfranco Nazzi, CEO of Biofarma Group“We will keep working to further develop the company at its full potential, seeking to seize all the multiple opportunities offered by such growing and evolving market”.

Gianfranco Nazzi replaces as CEO Maurizio Castorina, who will keep the role of Director in the Board of Directors of Biofarma and, thanks to his great experience, will continue to accompany and support the group in its important future challenges. The Board expresses its sincere gratitude to Mr. Castorina for the extraordinary results achieved in these years leading the company.

Press Release

© Biofarma Srl C.F. e P.IVA 02895910301
T. +39 0432 868711 F. +39 0432 868018
Via Castelliere, 2
33036 Mereto di Tomba (UD) Italy
Numero REA UD - 296214
Data di iscrizione al Registro delle
Imprese di UDINE: 01/07/2017
Numero d'iscrizione: 02895910301
Capitale sociale euro 3.000.000